参考文献/References:
[1]张声生,沈洪,郑凯,等.溃疡性结肠炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(8):3585-3589.
[2]周文鹏,白爱平.炎症性肠病常见基因多态性[J].胃肠病学,2018,23(3):177-180.
[3]Eichele DD,Kharbanda KK.Dextran sodium sulfate colitis murine model:An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis[J].World J Gastroenterol,2017,23(33):6016-6029.
[4]裴强伟,韩涛,宋小莉.中医方药口服治疗溃疡性结肠炎随机对照试验的系统评价[J].中药药理与临床,2013,29(4):157-160.
[5]王帅,包永睿,杨欣欣,等.白芍总苷对小鼠单核巨噬细胞作用时-效曲线研究[J].时珍国医国药,2017,28(3):541-544.
[6]李阳,郝艺照,傅熠俊,等.黄连素预防葡聚糖硫酸钠诱导溃疡性结肠炎的作用机制[J].中华中医药杂志,2017,32(8):3431-3435.
[7]任浪浪,唐志书,梁艳妮,等.马齿苋-肉桂联用提取工艺及其对DSS诱导溃疡性结肠炎的作用研究[J].中国现代中药,2019,21(2):182-187,198.
[8]牛莉,于泓苓.中药当归的化学成分分析与药理作用研究[J].中西医结合心血管病电子杂志,2018,6(21):98,100.
[9]成焕,王远亮.槟榔籽多酚对肠道微生物体外发酵的影响[J].食品与机械,2019,35(1):41-46.
[10]杨志军,邓毅,曼琼,等.甘草内生菌代谢物的抗炎作用[J].中国现代应用药学,2018,35(5):633-637.
[11]赵亚男,刘明,魏建梁,等.Wnt/β-catenin通路与NF-κB通路互相调控在创面愈合中的作用[J].中国病理生理杂志,2018,34(7):1339-1344.
[12]迟宏罡,于丰彦,张轶,等.芍药汤对实验性结肠炎小鼠Notch信号通路的影响[J].世界科学技术-中医药现代化,2017,19(4):694-700.
[13]Arbouzova NI,Zeidler MP.JAK/STAT signalling in drosophila:in sights into conserved regulatory and cellular functions[J].Development,2006,133(14):2605-2616.
[14]刘添文,陈新林,张北平,等.芍药汤加减联用西药治疗溃疡性结肠炎的Meta分析[J].中国中西医结合消化杂志,2016,24(6):425-430,432.
[15]郭逢源.加味芍药汤方与美沙拉嗪联用对溃疡性结肠炎患者的疗效及其对血清超敏C-反应蛋白水平的影响[J].抗感染药学,2018,15(7):1156-1158.
[16]李红波,程璐璐.芍药汤联合针刺治疗活动期溃疡性结肠炎[J].吉林中医药,2018,38(3):331-334.
[17]郁金.用芍药汤合痛泻要方加减治疗慢性溃疡性结肠炎的临床效果探讨[J].当代医药论丛,2018,16(10):206-207.
[18]赵春明,刘丽萍.芍药汤联合痛泻要方加减治疗慢性溃疡性结肠炎的效果及不良反应发生率研究[J].中西医结合心血管病电子杂志,2018,6(11):1-2.
[19]齐雪阳,张勤生,张春燕.芍药汤加减保留灌肠联合美沙拉嗪肠溶片治疗大肠湿热证溃疡性结肠炎[J].中国实验方剂学杂志,2016,22(19):149-153.
[20]陈建林,陈锦锋,韩宇斌,等.芍药汤保留灌肠对湿热型溃疡性结肠炎患者炎性因子的影响[J].中国中西医结合消化杂志,2018,26(11):938-940.
[21]周莉,刘刚,熊国卫,等.芍药汤加减联合艾灸对溃疡性结肠炎患者结肠黏膜修复的影响[J].中国处方药,2017,15(5):93-94.
[22]钟宇,郑学宝,叶华,等.芍药汤对溃疡性结肠炎大鼠TLR4/NF-κB通路的影响[J].中国中药杂志,2019(7):1-10.
[23]王移飞.芍药汤经HMGB1调节湿热内蕴型溃疡性结肠炎大鼠MyD88和NF-κB的机制研究[D].甘肃中医药大学,2018.
[24]聂军,袁晓梅,吴伟民.老年溃疡性结肠炎患者外周血血清降钙素原、C反应蛋白及白细胞介素-6水平的变化及临床意义[J].中国老年学杂志,2016,36(13):3232-3233.
[25]罗敏,吴强,朱蓉,等.芍药汤对胃肠湿热型溃疡性结肠炎大鼠Th17相关细胞因子的影响[J].中国医药导报,2016,13(13):8-11.
[26]王移飞,赵党生,王凤仪,等.芍药汤调节湿热型溃疡性结肠炎大鼠JAK2/STAT3和SOCS的分子机制[J].中国实验方剂学杂志,2017,23(23):97-102.
[27]王一帆,范恒.氧化苦参碱调控RhoA/ROCK信号通路介导溃疡性结肠炎E-cadherin及TGF-β的影响[J].中国实验方剂学杂志,2019,25(6):73-80.
[28]朱磊,沈洪,顾培青,等.黄芩苷对溃疡性结肠炎模型大鼠炎性反应、凋亡的影响及与PI3K/AKT通路的关系[J].中华中医药杂志,2017,32(9):4001-4004.
相似文献/References:
[1]杜丽君.穴位埋线疗法联合口服美沙拉嗪治疗溃疡性结肠炎的
护理分析[J].医学信息,2018,31(05):172.[doi:10.3969/j.issn.1006-1959.2018.05.063]
DU Li-jun.Nursing Analysis of Acupoint Catgut Embedding Therapy Combined with Oral Mesalazine in the Treatment of Ulcerative Colitis[J].Journal of Medical Information,2018,31(15):172.[doi:10.3969/j.issn.1006-1959.2018.05.063]
[2]张君红,李洪梅,井 洁,等.溃疡性结肠炎中西医结合治疗研究[J].医学信息,2018,31(09):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
ZHANG Jun-hong,LI Hong-mei,JING Jie,et al.Study on the Treatment of Ulcerative Colitis with Integrated Traditional Chinese and Western Medicine[J].Journal of Medical Information,2018,31(15):59.[doi:10.3969/j.issn.1006-1959.2018.09.019]
[3]华 琳,陈元旺,唐 静,等.溃疡性结肠炎患者外周血Tim-4 mRNA表达水平的变化及意义[J].医学信息,2019,32(21):161.[doi:10.3969/j.issn.1006-1959.2019.21.054]
HUA Lin,CHEN Yuan-wang,TANG Jing,et al.Changes and Significance of Tim-4 mRNA Expression in Peripheral Blood of Patients with Ulcerative Colitis[J].Journal of Medical Information,2019,32(15):161.[doi:10.3969/j.issn.1006-1959.2019.21.054]
[4]徐 杰.美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的效果比较[J].医学信息,2020,33(04):151.[doi:10.3969/j.issn.1006-1959.2020.04.049]
XU Jie.Comparison of Mesalazine and Sulfasalazine in Treating Ulcerative Colitis[J].Journal of Medical Information,2020,33(15):151.[doi:10.3969/j.issn.1006-1959.2020.04.049]
[5]牙韩清,郑琴芳,何志钧.溃疡性结肠炎相关结直肠癌手术治疗现况[J].医学信息,2020,33(07):44.[doi:10.3969/j.issn.1006-1959.2020.07.014]
YA Han-qing,ZHENG Qin-fang,HE Zhi-jun.Surgical Treatment of Ulcerative Colitis-related Colorectal Cancer[J].Journal of Medical Information,2020,33(15):44.[doi:10.3969/j.issn.1006-1959.2020.07.014]
[6]王莹洁,戴迟兵.益生菌在炎症性肠病中的应用研究[J].医学信息,2020,33(22):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
WANG Ying-jie,DAI Chi-bing.Study on the Application of Probiotics in Inflammatory Bowel Disease[J].Journal of Medical Information,2020,33(15):42.[doi:10.3969/j.issn.1006-1959.2020.22.013]
[7]朱 燕,刘大铭,刘全喜,等.溃疡性结肠炎中医诊疗思路[J].医学信息,2021,34(03):167.[doi:10.3969/j.issn.1006-1959.2021.03.048]
ZHU Yan,LIU Da-ming,LIU Quan-xi,et al.TCM Diagnosis and Treatment of Ulcerative Colitis[J].Journal of Medical Information,2021,34(15):167.[doi:10.3969/j.issn.1006-1959.2021.03.048]
[8]勾 熙,叶玉伟,刘 敏,等.血小板与淋巴细胞比值在溃疡性结肠炎患者病情评估中的价值[J].医学信息,2021,34(08):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
GOU Xi,YE Yu-wei,LIU Min,et al.The Value of the Ratio of Platelets to Lymphocytes in the Evaluation of Patients with Ulcerative Colitis[J].Journal of Medical Information,2021,34(15):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
[9]靖 洁.美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎的疗效[J].医学信息,2021,34(13):163.[doi:10.3969/j.issn.1006-1959.2021.13.045]
JING Jie.Efficacy of Mesalazine Combined with Live Bifidobacterium Triple Viable Bacteria in the Treatment of Ulcerative Colitis[J].Journal of Medical Information,2021,34(15):163.[doi:10.3969/j.issn.1006-1959.2021.13.045]
[10]项三妹,李 明.参苓白术散加减治疗脾虚湿蕴型溃疡性结肠炎的疗效及对血清IL-10、PLT、Fib水平的影响[J].医学信息,2022,35(08):162.[doi:10.3969/j.issn.1006-1959.2022.08.042]
XIANG San-mei,LI Ming.Efficacy of Shenlingbaizhu Powder in Treating Ulcerative Colitis with Spleen Deficiency and Damp Deposition Type and its Effect on Serum IL-10, PLT and Fib Levels[J].Journal of Medical Information,2022,35(15):162.[doi:10.3969/j.issn.1006-1959.2022.08.042]